NACE: National Association For Continuining Education 866-266-6223 9a am to 5 pm EST Mon-Fri
Member Login
(click your profession below)

CE Login
CME Login

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List iconCE News or CME News
Sign up for our Email Newsletters for information about upcoming courses and programs:

Conference Description

Emerging Challenges in Primary Care: 2005

August 20 - 21, 2005
The Westin Fort Lauderdale
400 Corporate Drive
Fort Lauderdale, FL 33334
800-937-8461

Tell a friend about this conference
Download the brochure for this conference
See how attendees evaluated this conference

CME Credits 10.75*

Nonrefundable registration fee: $0.

Target Audience: Physicians, Nurse Practitioners, and Physician Assistants.

Program Summary:
This program will provide Primary Care Physicians the opportunity to learn first hand from national thought leaders in their field. The goal is to provide a clearer understanding of several of the most common disease processes, in light of rapid scientific advances. By doing so, attendees will walk away with new insights and learn useful strategies to manage the challenges faced on a daily basis.

Learning Objectives:
At the conclusion of this CME activity, the participant will be able to:

  1. understand basic concepts of how intravascular ultrasound has changed our understanding of atherosclerosis progression and utilize latest statin trial data to promote disease regression and decrease clinical events
  2. more effectively manage heart failure and understand indications and implications of biventricular devices and cardiac defibrillators
  3. properly assess pre and post operative bariatric patients and understand potential complications and comorbidities
  4. evaluate, diagnose and treat patients with Diabetic Peripheral Neuropathy
  5. critically evaluate data and determine appropriate treatment options for patients with osteopenia
  6. recognize risk factors for Hepatitis C and screen appropriately with a clearer understanding of treatment options available
  7. utilize the latest data to effectively treat patients with GERD, Barrett’s epithelium, and extraesophageal manifestations of GERD
  8. understand the importance of pulmonary function testing (spirometry) and utilize the results in the diagnosis and treatment of COPD
  9. review national guidelines for the diagnosis, admission and treatment of patients with Community Acquired Pneumonia
  10. distinguish Depression and Anxiety from Bipolar Disorder, and utilize effective treatments available
  11. distinguish Mild Cognitive Impairment from Alzheimers dementia and utilize appropriate treatments based on the clinical features and stage of disease
  12. evaluate, stage and manage patients with chronic kidney disease
  13. understand and utilize the immune response modifying agent imiquimod to treat common dermatological problems such as keloids, actinic keratoses and basal cell carcinoma

Agenda:
Saturday, August 20, 2005
7:30-8:00    Continental Breakfast and Registration
8:00-8:10    Welcome Remarks
Gregg Sherman, MD
8:10-9:00    Aggressive Treatment of Coronary Artery Atherosclerosis: Is Regression Possible
Richard Kerensky, MD
9:00-9:50    Integrating Advanced Heart Failure Management with the use of Cardiac Devices: Role of the Primary Physician
Juan Aranda, MD
9:50-10:10    Break/Vendor Area
10:10-11:00    Bariatric Surgery for the Community Physician
Paul Wizman, MD
11:00-11:50    Peripheral Neuropathy
Robert Tannenberg, MD
11:50-12:40    Osteopenia
Yvonne Scherrer, MD
12:40-1:30    Lunch
1:30-2:20    Hepatitis C: An Approach to this Challenging Disease
Norman Gitlin, MD
2:20-3:10    Gastroesophageal Reflux Disease:Mechanisms and Current Trends
Jamie Barkin, MD
3:10-3:30    Break/Vendor Area
3:30-4:20    Spirometry and the Diagnosis of COPD
Tom Ferro, MD
4:20–5:00    Community Acquired Pneumonia
Tom Ferro, MD

Sunday, August 21, 2005
7:30-8:00    Continental Breakfast
8:00-8:10    Conference Update
Gregg Sherman, MD
8:10-9:00    Is it Depression or BiPolar Disorder?
Michael Ostacher, MD
9:00-9:50    Dementia
Walter Martinez, MD
9:50-10:10    Break/Vendor Area
10:10-11:00    Chronic Renal Disease
Biff Palmer, MD
11:00-11:50    Immune Response Modifiers: Emerging Indications
Brian Berman, MD
11:50-12:00    Conference Wrap Up

Faculty:
Juan Aranda, MD
Associate Professor of Medicine
Division of Cardiovascular Medicine
University of Florida College of Medicine, Gainesville, FL

Jamie S. Barkin, MD, FACP, MACG
Professor of Medicine, University of Miami, School of Medicine
Chief, Division of Gastroenterology, Mount Sinai Medical Center

Brian Berman, MD, PhD
Professor of Dermatology and Internal Medicine
The University of Miami School of Medicine

Thomas Ferro, MD
Professor of Internal Medicine and Physiology in
the Pulmonary and Critical Care Division of the Medical College
of Virginia at Virginia Commonwealth University,
Medical Director of Pulmonary & Critical Care Research
McGuire VA Medical Center in Richmond, VA

Norman Gitlin MD
Professor of Medicine, Emory University, Atlanta, GA

Richard Kerensky, MD
Associate Professor of Medicine
Director of Cardiac Catheterization Lab
Director of Interventional Cardiology
Shands Hospital University of Florida

Walter C. Martinez, MD, FAAN
Director Memory Disorder Center
Director Premiere Research Institute
Associate Clinical Professor of Neurology at
Nova Southeastern University

Michael J. Ostacher, MD, MPH
Harvard Bipolar Research Program
Massachusetts General Hospital
Instructor, Harvard Medical School

Biff Palmer, MD
Professor of Internal Medicine
Nephrology Fellowship Program Director
UT Southwestern Medical Center, Dallas, TX

Yvonne Scherrer, MD
Medical Director/Director of Clinical Research
Centre for Rheumatology, Immunology and Arthritis
Fort Lauderdale, FL

Robert Tannenberg, MD
Director, Diabetes and Obesity Center,
East Carolina University, Greenville, NC

Paul Wizman, MD
Medical Director Bariatrics
NorthWest Medical Center

Program Chair: Gregg Sherman, MD

Activity Director: Alan Goodstat, LCSW

*Continuing Education Information
This activity has been reviewed and is acceptable for up to 10.75 Prescribed credit hours by the American Academy of Family Physicians.

This program was supported through educational grants from the following companies: 3M, Amylin, Boehringer Ingelheim, Forest Pharmaceuticals, Kyphon, Merck, Novartis, Omni Health Care, Pfizer, P&G, Roche, Sankyo, sanofi-aventis, Sepracor, Takeda, United Stetaes Surgical/Tyco Healthcare.